SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-340955
Filing Date
2014-09-15
Accepted
2014-09-15 07:00:34
Documents
3
Period of Report
2014-09-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d788350d8k.htm 8-K 16784
2 EXHIBIT 99.1 d788350dex991.htm EX-99.1 9466
3 GRAPHIC g788350g55c81.jpg GRAPHIC 7885
  Complete submission text file 0001193125-14-340955.txt   38841
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 141102110
SIC: 3841 Surgical & Medical Instruments & Apparatus